Clinical Trials News Live Feed
March 3, 2026·about 6 hours ago·via Stock Titan

Stock Titan delivers a live feed of clinical trials news, spotlighting key developments across oncology and beyond. Lung cancer trials now enroll patients in 2026, while RECOVER-AUTONOMIC shares first results on ivabradine for Long COVID-related POTS at the American College of Cardiology conference on March 28. AIM ImmunoTech plans a Phase 3 trial of Ampligen for late-stage pancreatic cancer after promising Phase 2 data with durvalumab.
Explore More
Dodgers' Miller Eyes Role Shift Amid Injury Worry

Magic Trend Up but Face More Work Ahead

Army Chief: No Terrorist Sanctuary in Nigeria
French Sports Nutrition Brand Eric Favre Hits 1 Million Customers

Kalshi Code ELITE Unlocks $10 Bonus on All Trades

Daniel Radcliffe Admits He’d Rather His Son Avoid Hollywood Altogether
Family Proof
6 Highest Grossing Movies in 2025
SnipDaily
ANTM’s Most Controversial Shoots Resurface in Netflix’s New Docuseries
SnipDaily
Amazon Music Unlimited Family Annual Plan Going From $199 to $219
SnipDaily